Frontier Jet Kills Pedestrian On Denver Runway During Takeoff

Frontier Jet Kills Pedestrian On Denver Runway During Takeoff

A pedestrian was killed Friday after being hit by a Frontier Airlines passenger plane during take off at Denver airport, officials said. The deceased was hit by the aircraft while the plane was taking off to Los Angeles, AP reported. The pedestrian has has not been identified, Denver International Airport confirmed in an X post.…

Read More

U.S. Sanctions Nine Chinese and Hong Kong Entities for Arming Iran — Days Before Trump’s Summit With Xi

U.S. Sanctions Nine Chinese and Hong Kong Entities for Arming Iran — Days Before Trump’s Summit With Xi

The United States sanctioned nine mainland Chinese and Hong Kong companies and individuals on Friday, accusing them of helping Iran’s military procure weapons and the raw materials needed to build its Shahed drones and ballistic missiles — in a move that risks complicating President Donald Trump’s planned visit to China next week for a long-awaited…

Read More

Canvas Hackers Warn ‘Pay or Leak’ as Ransom Deadline Looms Over 30 Million Students’ Stolen Records

Canvas Hackers Warn ‘Pay or Leak’ as Ransom Deadline Looms Over 30 Million Students’ Stolen Records

Cybercrime group ShinyHunters has seized control of Canvas login pages at hundreds of universities, giving the platform’s parent company until 12 May 2026 to pay up or risk seeing stolen data from tens of millions of students made public. Canvas, the cloud-based learning management system operated by education technology company Instructure, serves more than 30…

Read More

FDA Extends Review of Eisai, Biogen Alzheimer’s Drug

FDA Extends Review of Eisai, Biogen Alzheimer’s Drug

KEY POINTS FDA extends review of weekly subcutaneous LEQEMBI IQLIK for early Alzheimer’s initial treatment to Aug. 24, 2026 Review delay follows a major amendment after an FDA request for additional information FDA has not raised concerns about approvability, while subcutaneous maintenance use was cleared in 2025 The agency pushed its decision on weekly subcutaneous…

Read More